Provided by Tiger Trade Technology Pte. Ltd.

Legend Biotech

19.91
-0.5800-2.83%
Volume:1.36M
Turnover:27.18M
Market Cap:3.87B
PE:-39.76
High:20.52
Open:20.22
Low:19.76
Close:20.49
52wk High:37.50
52wk Low:16.24
Shares:194.49M
Float Shares:91.34M
Volume Ratio:1.02
T/O Rate:1.49%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5008
EPS(LYR):-1.6200
ROE:-8.08%
ROA:-1.92%
PB:3.15
PE(LYR):-12.29

Loading ...

Top News Today/Canada: Barrick Settles Newmont Dispute, Clearing Way to List Its Gold Assets

Dow Jones
·
Aug 11

Legend Biotech Corporation Expected to Post Earnings of 7 Cents a Share - Earnings Preview

Reuters
·
Aug 08

Earning Preview: Legend Biotech this quarter’s revenue is expected to increase by 55.36%, and institutional views are positive

Earnings Agent
·
Aug 05

Legend Biotech Interim CEO Alan Bash Files Initial Beneficial Ownership Statement

Reuters
·
Aug 04

Legend Biotech (LEGN) CEO Exit Raises Questions, Is The Stock Still Cheap?

Simply Wall St.
·
Jul 31

Legend Biotech to Host Investor Call on Second-quarter 2026 Results

Reuters
·
Jul 28

Legend Biotech Corp : Raymond James Cuts Target Price to $58 from $86

THOMSON REUTERS
·
Jul 28

Legend Biotech Price Target Maintained with a $65.00/Share by HC Wainwright & Co.

Dow Jones
·
Jul 28

Buy Rating Reiterated as Strong CARVYKTI Momentum and Attractive Valuation Support Unchanged $65 Price Target

TIPRANKS
·
Jul 28

Under the Radar: Legend Stock Tumbles After CEO's Abrupt Departure

Dow Jones
·
Jul 28

Legend Biotech's In Vivo CAR-T Cell Therapy Data Validates Approach, RBC Capital Markets Says

MT Newswires Live
·
Jul 27

Legend Biotech is Maintained at Outperform by RBC Capital

Dow Jones
·
Jul 27

Legend Biotech falls -12.5%

TIPRANKS
·
Jul 27

Legend Biotech price target lowered to $59 from $63 at RBC Capital

TIPRANKS
·
Jul 27

RBC Cuts Price Target on Legend Biotech to $59 From $63, Keeps Outperform Rating

MT Newswires Live
·
Jul 27

Legend Biotech Shares Down 3.7% Premarket; Ying Huang Steps Down as CEO and Board Member, Alan Bash Appointed Interim CEO

THOMSON REUTERS
·
Jul 27

Legend Biotech Names Alan Bash Interim CEO After Ying Huang Resigns

Reuters
·
Jul 27

Legend Biotech Corp - Ying Huang Steps Down as CEO and Board Member; to Remain as Advisor Through August

THOMSON REUTERS
·
Jul 27

Legend Biotech Corp - Alan Bash Appointed Interim CEO

THOMSON REUTERS
·
Jul 27

Legend Biotech Corp - Board Initiates Search for Permanent CEO Successor

THOMSON REUTERS
·
Jul 27